Explore more price target data and ratings for Enovis Corporation on the Forecasts tab, and track all previous and future analyst recommendations for Enovis Corporation in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This informat…
What Happened? Shares of medical technology company Enovis Corporation NYSE:ENOV fell 12.8% in the afternoon session after the company reported second-quarter earnings, where a weaker outlook and declining profitability overshadowed headline beats.The company reported revenue of $582.8 million and…
Q2 2026 delivered 5% organic growth, margin expansion, and strong free cash flow, driven by new product launches and commercial execution. Guidance for 2026 is reaffirmed, with expectations for continued growth, margin improvement, and positive cash flow despite inflation and international headwind…
Enovis CORP reported results for the quarter ended 2026 showing revenue of $582.78M, a 3.2% increase versus the prior-year quarter, and a substantially smaller net loss of ($1.19M) compared with ($36.74M) a year earlier; diluted EPS was ($0.02) versus ($0.64) in the prior-year quarter — per the com…
Dallas, TX, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) NYSE:ENOV, an innovation-driven medical technology growth company, today announced its financial results for the second quarter ended July 3, 2026. The Company will host an investor conference call and liv…
Medical technology company Enovis Corporation NYSE:ENOV will be reporting earnings this Thursday morning. Here’s what to expect.Enovis beat analysts’ revenue expectations last quarter, reporting revenues of $589.2 million, up 5.4% year on year. It was a satisfactory quarter for the company, with a…
Enovis (NYSE:ENOV) will report Q2 2026 results and host an investor call with webcast on Aug. 6 at 8:30 a.m. ET, following a July 13 U.S. launch of the CT‑RevitL PBM laser for Companion Animal Health featuring COMPASS guidance to improve dosing precision and workflow.Previous Week Recap…
What Happened? Shares of medical technology company Enovis Corporation NYSE:ENOV jumped 3.6% in the afternoon session after the company announced the U.S. launch of CT-RevitL, a new veterinary laser therapy system from its Companion Animal Health business.The system uses photobiomodulation therapy…
(16:19 GMT) Enovis Price Target Cut to $32.00/Share From $36.00 by Evercore ISI Group
